PMC:7534795 / 44089-44398
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T329 | 30-38 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T330 | 134-142 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T367 | 0-79 | Sentence | denotes | • Barcitinib for hospitalized COVID-19 patients • Non-randomized clinical trial |
| T368 | 80-142 | Sentence | denotes | • Any adult patient hospitalized with moderate/severe COVID-19 |
| T369 | 143-195 | Sentence | denotes | • Barcitinib + standard care vs. standard care alone |
| T370 | 196-309 | Sentence | denotes | • Primary outcome of clinical status after 15 days • Barcitinib 2 mg orally daily for 10 days (NCT04321993, 2020) |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1310 | 39-47 | Species | denotes | patients | Tax:9606 |
| 1311 | 92-99 | Species | denotes | patient | Tax:9606 |
| 1349 | 30-38 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1350 | 134-139 | Disease | denotes | COVID | MESH:C000657245 |